These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 25117266)
1. Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119. Engelstoft MS; Norn C; Hauge M; Holliday ND; Elster L; Lehmann J; Jones RM; Frimurer TM; Schwartz TW Br J Pharmacol; 2014 Dec; 171(24):5774-89. PubMed ID: 25117266 [TBL] [Abstract][Full Text] [Related]
2. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119. Hassing HA; Fares S; Larsen O; Pad H; Hauge M; Jones RM; Schwartz TW; Hansen HS; Rosenkilde MM Biochem Pharmacol; 2016 Nov; 119():66-75. PubMed ID: 27569424 [TBL] [Abstract][Full Text] [Related]
3. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386 [TBL] [Abstract][Full Text] [Related]
4. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa. Tough IR; Forbes S; Herzog H; Jones RM; Schwartz TW; Cox HM Endocrinology; 2018 Apr; 159(4):1704-1717. PubMed ID: 29471473 [TBL] [Abstract][Full Text] [Related]
5. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Lauffer LM; Iakoubov R; Brubaker PL Diabetes; 2009 May; 58(5):1058-66. PubMed ID: 19208912 [TBL] [Abstract][Full Text] [Related]
6. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM Biol Chem; 2014 Apr; 395(4):453-64. PubMed ID: 24323890 [TBL] [Abstract][Full Text] [Related]
7. The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. Stone VM; Dhayal S; Smith DM; Lenaghan C; Brocklehurst KJ; Morgan NG Br J Pharmacol; 2012 Apr; 165(8):2758-70. PubMed ID: 22029844 [TBL] [Abstract][Full Text] [Related]
8. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141 [TBL] [Abstract][Full Text] [Related]
9. Parameterization of the GPR119 Receptor Agonist AR231453. Hamilton J; Kotsikorou E J Comput Chem; 2018 Jan; 39(1):35-41. PubMed ID: 29023843 [TBL] [Abstract][Full Text] [Related]
10. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways. Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag. Chepurny OG; Bertinetti D; Diskar M; Leech CA; Afshari P; Tsalkova T; Cheng X; Schwede F; Genieser HG; Herberg FW; Holz GG Mol Endocrinol; 2013 Aug; 27(8):1267-82. PubMed ID: 23798572 [TBL] [Abstract][Full Text] [Related]
12. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms. Flock G; Holland D; Seino Y; Drucker DJ Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156 [TBL] [Abstract][Full Text] [Related]
13. Mutation-Guided Unbiased Modeling of the Fat Sensor GPR119 for High-Yield Agonist Screening. Norn C; Hauge M; Engelstoft MS; Kim SH; Lehmann J; Jones RM; Schwartz TW; Frimurer TM Structure; 2015 Dec; 23(12):2377-2386. PubMed ID: 26526849 [TBL] [Abstract][Full Text] [Related]